Page 4 - Oxford University

Oxford-AstraZeneca Covid-19 vaccine shows immune response in older adults

The vaccine causes few side effects and provokes a response in T-cells that target the virus within 14 days of the first dose and a protective antibody response within 28 days of the booster dose

India Coronavirus Dispatch: Oxford vaccine may be a better fit for India

Delhi cemetary running out of space, 74 per cent Delhiites say they want markets shut, Covid immune response is enduring, may protect for decades-news on how the country is coping with the pandemic

Pfizer vaccine's -70 degree storage norm tough for most nations: V K Paul

Limited number of doses would not be enough to meet India's demand, adds Niti Aayog member

Indian economy may be recovering faster than anticipated: Oxford Economics

The Indian economy is seen recovering faster than expected and the Reserve Bank is likely to have come to an end of the rate easing cycle, according to global forecasting firm Oxford Economics

'Great day for humanity': Pfizer says Covid-19 vaccine over 90% effective

President-elect Joe Biden said the news was excellent but did not change the fact that face masks, social distancing would be needed well into next year

Britain prepares for Covid-19 vaccine as Oxford forecasts result this year

There are more than 200 candidates under development and the vaccine being developed by Oxford and licensed to British drugmaker AstraZeneca is seen as a front-runner

Oxford Covid vaccine trial results due this year, chief investigator says

The Oxford/AstraZeneca vaccine is expected to be one of the first from big pharma to be submitted for regulatory approval, along with Pfizer and BioNTech's candidate

UK starts accelerated review for AstraZeneca's potential Covid-19 vaccine

"We confirm the MHRA's (Medicines and Healthcare Products Regulatory Agency) rolling review of our potential Covid-19 vaccine," an AstraZeneca spokesman said

Oxford Covid-19 vaccine prompts immune response among adults: AstraZeneca

The Financial Times reported that the vaccine, being developed by Oxford and AstraZeneca, triggers protective antibodies and T-cells in older age groups. It cited two people familiar with the finding

AstraZeneca's volunteer who died didn't get Covid-19 vaccine: Report

Brazil's health authority Anvisa said it had been informed on Monday of the study volunteer's death and had received a partial report from an international committee assessing the trial's safety

Oxford Covid-19 vaccine doing everything expected', independent study finds

The experts say that the novel analysis provides even greater clarity and detail about how the vaccine successfully provokes a strong immune response.

Oxford says trial of its Covid vaccine will continue amid death report

The university said it can''t comment on specific incidents but an independent review found no reason to be concerned about the safety of the Brazilian trial

Oxford scientists develop five-minute rapid coronavirus antigen test

The university said it hoped to start product development of the testing device in early 2021 and have an approved device available six months afterwards

Yale, Oxford campuses in India? Modi govt pushing for changes in laws

The legislation -- which will regulate the operation of foreign universities -- is being prepared for approval by the parliament, where the government retains a significant majority

Oxford Univ Covid-19 vaccine could be rolled out within 6 months: Report

There is growing hope that a Covid-19 vaccine may be given the green light by health regulators by the end of this year to be rolled out for a vaccination programme in six months' time or even less

Oxford to study anti-inflammatory drug Humira as potential Covid treatment

Humira is used to treat a range of conditions including rheumatoid arthritis, Crohn's disease, ulcerative colitis and psoriasis

Serum Institute gets DCGI nod to resume clinical trial of Oxford vaccine

DCGI gave permission to Serum Institute to resume clinical trial of the Oxford Covid-19 vaccine candidate in the country

Halting Oxford's Covid-19 vaccine trial is not a setback; it shows prudence

Melbourne-based biotechnology company CSL has committed to producing and supplying more than 30 million doses of the vaccine to Australians if it's found to be safe and effective

AstraZeneca still aiming for Oxford Covid-19 vaccine by year-end, says CEO

Soriot sought to reassure investors after the company and its partner confirmed earlier this week that they had temporarily stopped giving people the experimental shot

Covid-19: Indian sites await DCGI nod to restart Oxford vaccine trial

The Drug Controller General of India (DCGI) V G Somani will take a call after he receives data from the Data and Safety Monitoring Board (DSMB) in the UK as well as India